HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ulta profit skyrockets 178%

This article was originally published in The Rose Sheet

Executive Summary

In its fiscal first quarter ended May 1, specialty retailer Ulta posted earnings of $13.7 mil., up 177.7% from the same period last year due to a mix of market share growth, "dynamic" marketing for products and improved business operations, the Bolingbrook, Ill.-based firm announces June 3. Sales increased 19.1% to $320.2 mil. for the quarter. In its second fiscal quarter, Ulta will expand its prestige beauty offerings, introducing Philosophy skin-care, for example. Net sales for the period are expected to be in the range of $311 mil. to $317 mil., compared with net sales of $273.5 mil. in the second quarter of fiscal 2009

In its fiscal first quarter ended May 1, specialty retailer Ulta posted earnings of $13.7 mil., up 177.7% from the same period last year due to a mix of market share growth, "dynamic" marketing for products and improved business operations, the Bolingbrook, Ill.-based firm announces June 3. Sales increased 19.1% to $320.2 mil. for the quarter. In its second fiscal quarter, Ulta will expand its prestige beauty offerings, introducing Philosophy skin-care, for example. Net sales for the period are expected to be in the range of $311 mil. to $317 mil., compared with net sales of $273.5 mil. in the second quarter of fiscal 2009.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016981

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel